Andermann syndrome

Andermann syndrome

Overview 

 Andermann syndrome, also known as ACCPN, is a rare, severe neurodegenerative genetic disorder. It primarily features the underdevelopment or absence of the tissue connecting the two halves of the brain (corpus callosum), along with progressive muscle weakness and intellectual disability.

Symptoms

A Neurological Complications

Progressive Neuropathy: Early muscle weakness (hypotonia) transitions into progressive motor deterioration, causing severe muscle wasting (amyotrophy) and flaccid tetraplegia. Affected individuals usually lose the ability to walk and become wheelchair-bound by adolescence.

Cranial Nerve Defects: Damage to cranial nerves can cause facial muscle weakness, drooping eyelids (ptosis), and gaze palsy (difficulty moving the eyes in certain directions).

Seizures: Epilepsy and abnormal electrical activity in the brain occur in many patients.Sensory Loss: Patients suffer from absent or severely diminished sensory responses (areflexia).

Skeletal and Physical Complications

Severe Scoliosis: Rapidly worsening abnormal curvature of the spine typically develops during adolescence (around ages 9 to 11) and often requires surgical intervention.

Joint Contractures: Chronic muscle imbalance and immobility lead to joint deformities and tightness that permanently restrict the range of motion in the limbs.

Cognitive and Psychiatric Complications

Intellectual Disability: Global developmental delays are universal, ranging from mild to severe impairment.

Psychiatric Symptoms: Many patients experience severe psychiatric and behavioral disturbances, particularly as they reach adolescence. These include severe depression, anxiety, agitation, paranoid delusions, hallucinations, and autism-like behavioral patterns.

Prognosis and Systemic Complications

Respiratory Insufficiency: The most severe complication and the primary cause of shortened life expectancy is respiratory insufficiency. Weakening of the respiratory muscles severely compromises lung function.

Reduced Life Expectancy: While patients typically survive into adulthood, life expectancy is significantly shortened, with many individuals passing away in their mid-20s to 30s primarily due to respiratory and systemic complications.ndermann syndrome is a rare genetic disorder characterized by agenesis of the corpus callosum and severe progressive sensory and motor peripheral neuropathy. Its primary symptoms include profound muscle weakness, hypotonia, loss of deep tendon reflexes, severe developmental delays, intellectual disability, and late-onset psychiatric complications like paranoid psychosis and depression.

A more detailed breakdown of the clinical symptoms associated with the syndrome includes:

Neurological and Muscular Symptoms

Sensory and Motor Neuropathy: Progressive damage to the nerves causes severe muscle wasting (amyotrophy) and a loss of sensation in the limbs.

Hypotonia and Areflexia: Affected infants exhibit abnormally weak muscle tone and absent reflexes.

Delayed Ambulation: Children generally do not walk until they are 3 to 4 years of age and typically lose the ability to walk independently by their teenage years, eventually becoming wheelchair-bound.

Seizures: Some individuals experience epileptiform activity and seizures.

Brain Malformation and Cranial Features

Callosal Agenesis: About two-thirds of individuals are missing the corpus callosum entirely, while others have a partially formed structure.

Cranial Nerve Dysfunction: This can result in facial muscle weakness, drooping eyelids, and difficulty tracking objects with the eyes.

Distinctive Facial Features: Individuals may have a wide, short skull (brachycephaly), an elongated and asymmetrical face, widely spaced eyes (ocular hypertelorism), a small upper jaw, and a high arched palate.

Skeletal Deformities

Scoliosis: Abnormal curvature of the spine frequently develops and may require surgical correction.

Contractures: Joint stiffness and deformities restrict movement in certain joints.

Foot Anomalies: The big toe may cross over other toes, and some individuals experience partial fusion of the second and third toes.

Cognitive and Psychiatric Symptoms

Intellectual Disability: Global developmental delays and intellectual deficits range from mild to severe.

Psychiatric Manifestations: During adolescence or early adulthood, patients may experience severe psychiatric issues, including apathy, social withdrawal, terrifying hallucinations, paranoid delusions, and autistic-like behaviors.

Complications

Neurological Complications

Progressive Neuropathy: Early muscle weakness (hypotonia) transitions into progressive motor deterioration, causing severe muscle wasting (amyotrophy) and flaccid tetraplegia. Affected individuals usually lose the ability to walk and become wheelchair-bound by adolescence.

Cranial Nerve Defects: Damage to cranial nerves can cause facial muscle weakness, drooping eyelids (ptosis), and gaze palsy (difficulty moving the eyes in certain directions).

Seizures: Epilepsy and abnormal electrical activity in the brain occur in many patients.

Sensory Loss: Patients suffer from absent or severely diminished sensory responses (areflexia).

Skeletal and Physical Complications

Severe Scoliosis: Rapidly worsening abnormal curvature of the spine typically develops during adolescence (around ages 9 to 11) and often requires surgical intervention.

Joint Contractures: Chronic muscle imbalance and immobility lead to joint deformities and tightness that permanently restrict the range of motion in the limbs.

Cognitive and Psychiatric Complications

Intellectual Disability: Global developmental delays are universal, ranging from mild to severe impairment.

Psychiatric Symptoms: Many patients experience severe psychiatric and behavioral disturbances, particularly as they reach adolescence. These include severe depression, anxiety, agitation, paranoid delusions, hallucinations, and autism-like behavioral patterns.

Prognosis and Systemic Complications

Respiratory Insufficiency: The most severe complication and the primary cause of shortened life expectancy is respiratory insufficiency. Weakening of the respiratory muscles severely compromises lung function.

Reduced Life Expectancy: While patients typically survive into adulthood, life expectancy is significantly shortened, with many individuals passing away in their mid-20s to 30s primarily due to respiratory and systemic complications.

Risk Factors

To develop Andermann syndrome, an individual must inherit one altered gene from each parent. The risk breakdown in each pregnancy for two carrier parents includes:

Affected child (25% risk): Inherits two altered copies of the SLC12A6 gene, leading to the clinical manifestations of the syndrome.

Carrier child (50% risk): Inherits one altered copy of the gene, remaining healthy and asymptomatic.

Unaffected child (25% risk): Inherits two working copies of the gene

Ethnic and Ancestral Factors

While it can affect any population, Andermann syndrome—also known as Charlevoix-Saguenay disease or hereditary motor and sensory neuropathy with agenesis of the corpus callosum (HMSN/ACC)—is historically most prevalent in the Charlevoix-Saguenay region of Quebec, Canada.Founder Variant: The exceptionally high occurrence in this French-Canadian subpopulation is linked to a specific "founder variant" in the SLC12A6 gene.

Carrier Frequency: Carrier rates are generally higher in specific ancestral groups, such as the French-Canadian population and the Ashkenazi Jewish population.

Causes

The root causes and biological mechanisms of the condition involve several specific factors:

Gene Mutation: The SLC12A6 gene is responsible for creating a potassium-chloride cotransporter protein (KCC3). Mutations disrupt the function of this protein, making it unable to regulate ion concentration gradients inside axons.

Autosomal Recessive Inheritance: The condition is strictly an autosomal recessive disease. A person must inherit two mutated copies of the gene—one from each parent. Carriers who have only one mutated copy do not exhibit symptoms but have a 25% chance of passing the condition to a child.

Axonal Damage & Swelling: The lack of functional KCC3 protein causes abnormal ionic states within axons, leading to axonal swelling, aberrant growth (axonomas), and hindered axonal transport.

Nerve Disruption: This damage causes widespread progressive motor and sensory neuropathy, as well as agenesis (failure to form properly) of the corpus callosum—the band of nerve tissue connecting the brain's hemispheres.

Diagnosis

Clinical Evaluation: Identifying delayed motor milestones (typically evident around 4 to 6 months of age), severe hypotonia (low muscle tone), absent deep tendon reflexes, and progressive muscle wasting.

Neuroimaging (Brain MRI): Scans reveal the hallmark structural defect of the brain: complete or partial absence (agenesis) of the corpus callosum.

Electrophysiological Testing: Electromyography (EMG) and nerve conduction studies will typically show absent sensory nerve action potentials in infancy and severe motor/sensory nerve degeneration.

Molecular Genetic Testing: Confirmed by identifying pathogenic variants in the SLC12A6 (KCC3) gene.

Treatment 

Treatment focuses on managing specific manifestations of the disease:

Motor and Mobility Support: Individuals often use canes, walkers, or wheelchairs as neuropathy progresses. Physical and occupational therapy are required to maintain movement, improve coordination, and prevent joint contractures.

Orthopedic Interventions: Corrective surgery is frequently necessary for severe scoliosis (abnormal curvature of the spine), which typically develops in the early teenage years.

Neurological and Psychiatric Care: Low-dose neuroleptic medications are often prescribed to treat psychiatric manifestations, such as psychotic episodes, which usually appear in adolescence. Valproate or other anticonvulsants may be used if the individual experiences seizures.

Developmental Support: Early intervention programs and educational resources are critical to help children with the disorder navigate cognitive delays and achieve developmental milestones.

Type of Doctor Department : A Neurologist